temsirolimus
Generic: temsirolimus
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
temsirolimus
Generic Name
temsirolimus
Labeler
fresenius kabi usa, llc
Dosage Form
KIT
Routes
Manufacturer
Identifiers & Regulatory
Product NDC
65219-200
Product ID
65219-200_2b33d5f1-198e-41ef-ac78-ccfd27fc137a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207383
Listing Expiration
2026-12-31
Marketing Start
2020-11-20
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65219200
Hyphenated Format
65219-200
Supplemental Identifiers
RxCUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
temsirolimus (source: ndc)
Generic Name
temsirolimus (source: ndc)
Application Number
ANDA207383 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/ml
- 0.2 ml
- 1.8 ml
- 2.2 ml
Packaging
- 1 KIT in 1 KIT (65219-200-05) * 1 mL in 1 VIAL, SINGLE-DOSE (65219-205-05) * 1.8 mL in 1 VIAL, SINGLE-DOSE (65219-202-05)
Packages (1)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2b33d5f1-198e-41ef-ac78-ccfd27fc137a", "openfda": {"rxcui": ["722289"], "spl_set_id": ["1c207bed-10e3-46f0-ad2c-69d5e5c97736"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 KIT (65219-200-05) * 1 mL in 1 VIAL, SINGLE-DOSE (65219-205-05) * 1.8 mL in 1 VIAL, SINGLE-DOSE (65219-202-05)", "package_ndc": "65219-200-05", "marketing_start_date": "20201120"}], "brand_name": "Temsirolimus", "product_id": "65219-200_2b33d5f1-198e-41ef-ac78-ccfd27fc137a", "dosage_form": "KIT", "product_ndc": "65219-200", "generic_name": "Temsirolimus", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Temsirolimus", "application_number": "ANDA207383", "marketing_category": "ANDA", "marketing_start_date": "20201120", "listing_expiration_date": "20261231"}